# Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

> clinical trial · VERIFIED · 2026-07-13

Status: RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Advanced Esophageal Adenocarcinoma

- Company: National Cancer Institute (NCI)
- Sector: Advanced Esophageal Adenocarcinoma
- Primary source: https://clinicaltrials.gov/study/NCT06203600

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.